A clinical trial is a research study that tests whether a new medical treatment, device, or approach works better than what doctors currently use. For asthma specifically, clinical trials might test new medications, different inhaler designs, novel delivery methods, or combination therapies that haven't been widely prescribed yet. Researchers conduct these trials to gather solid evidence about safety and effectiveness before the treatment becomes available to the general public.
Learn About Paying Your FGUA Bill Online →
The asthma research landscape has expanded significantly over the past decade. According to the National Heart, Lung, and Blood Institute, there are currently hundreds of asthma-related clinical trials in various stages across the United States. These trials range from small Phase 1 studies involving a handful of participants to large Phase 3 studies with thousands of people. Each phase serves a specific purpose: early phases focus on safety, while later phases measure how well a treatment works compared to existing options.
Why would someone consider joining an asthma clinical trial? Participants gain access to cutting-edge treatments before they're widely available. Some people participate because their current asthma management isn't working well enough—they experience frequent flare-ups, need multiple daily medications, or struggle with side effects from their current prescriptions. Others join because they want to contribute to medical science and help future patients with asthma.
Understanding the basic structure of clinical trials helps you evaluate whether participation might fit your situation. Trials aren't random experiments—they follow strict protocols reviewed by independent ethics boards. Every trial has specific requirements about who can participate, what the study involves, and what researchers will measure. The information in this guide will walk you through these components so you can make an informed decision about whether exploring clinical trial options makes sense for your asthma care.
Practical takeaway: Clinical trials test new asthma treatments through structured research. Learning what trials exist and how they work gives you another angle to think about asthma management beyond standard prescriptions.
Clinical trials progress through phases, each with different purposes and sizes. Understanding these phases helps you recognize what stage a particular trial is at and what that means about the treatment being tested.
Free Guide to Pay by Plate Illinois Billing →
Phase 1 trials involve small groups—typically 20 to 100 people—and focus primarily on safety. Researchers give participants the new treatment and watch carefully for side effects, determine safe dosage ranges, and observe how the body processes the medication. For asthma treatments, Phase 1 might test an experimental inhaler additive or a new biologic therapy in a small group to ensure it doesn't cause unexpected reactions. These early trials often involve healthy volunteers or people with mild asthma, though not always.
Phase 2 trials expand to 100 to 500 participants and start examining whether the treatment actually works. Researchers confirm that the asthma treatment reduces symptoms, improves lung function, or prevents flare-ups better than a placebo or current standard treatment. A Phase 2 asthma trial might measure how much a new medication improves forced expiratory volume (FEV1, a key lung function measure) or how many asthma attacks participants experience during the study period.
Phase 3 trials involve hundreds to thousands of people and compare the new treatment against the current standard of care. These large studies confirm that the new asthma treatment works as hoped and identify any side effects that might be rare but important. Phase 3 asthma trials often last months or even years, giving researchers time to see how well the treatment works across different seasons, activity levels, and trigger exposures.
Phase 4 trials (also called post-market surveillance) happen after a treatment is already approved and available. Researchers continue monitoring long-term effects, potential interactions with other medications, and outcomes in broader populations than were studied in Phase 3.
Understanding where a trial sits in this progression tells you something about how much is already known about safety and effectiveness. Earlier phases gather basic safety data, while later phases confirm real-world benefit.
Practical takeaway: Earlier phase trials focus on safety; later phases confirm a treatment works. Knowing which phase a trial is in helps you understand what researchers are still investigating.
Asthma research today focuses on several treatment approaches, ranging from improved versions of existing medication types to entirely new categories of drugs. Knowing what kinds of treatments are in trials helps you understand the direction of asthma care.
Free Guide to Mold Removal Methods for Walls →
Biologic therapies represent one major research area. These medications target specific parts of the immune system that trigger asthma inflammation. Several biologics are already on the market (like dupilumab, reslizumab, and mepolizumab), but trials continue testing new biologics for patients whose asthma doesn't respond well to existing biologic options or who have specific asthma phenotypes. For example, some trials test biologics targeting eosinophil production for people with eosinophilic asthma, while others target IgE pathways for allergic asthma. The pharmaceutical industry invested approximately $4.5 billion in asthma research and development in recent years, with biologics representing a significant portion of that investment.
Small molecule medications—traditional pill-based drugs—remain an active research area. Trials test new oral corticosteroid-sparing approaches, novel bronchodilators that work differently than existing ones, and combinations that might allow lower doses of individual medications. Some trials examine whether new formulations can be taken less frequently, potentially improving medication adherence.
Device and delivery innovations are also being studied. Researchers test smart inhalers that track usage and provide feedback, dry powder inhalers with different mechanisms, nebulizer systems designed for specific age groups, and even transdermal patches or injectable medications that eliminate the need for inhalers altogether. Some trials examine whether different delivery methods work better for particular populations—for instance, studies on inhalers designed specifically for elderly patients or young children.
Combination therapies represent another research focus. Rather than developing entirely new medications, some trials test whether existing drugs work better when combined in new ways or at different doses. For example, a trial might test whether combining a lower-dose inhaled corticosteroid with a specific bronchodilator works as well as higher-dose single medications.
Precision medicine trials are emerging, too. These studies attempt to match specific asthma phenotypes (severe eosinophilic asthma, aspirin-sensitive asthma, exercise-induced asthma, and others) with the treatments most likely to work for that specific type.
Practical takeaway: Asthma trials range from completely new drug categories to improvements on existing treatments. The type of trial matters if you have a specific asthma pattern that hasn't responded well to current options.
Several established resources list asthma clinical trials currently recruiting participants. ClinicalTrials.gov, operated by the National Library of Medicine, is the primary U.S. database where researchers must register most clinical trials. You can search by condition (asthma), location, trial phase, and other filters. The site provides detailed information about each trial's purpose, requirements, and contact information.
How to Delete Your Fitbit Account Guide →
Other resources include the Asthma and Allergy Foundation of America (AAFA) website, which maintains lists of trials and educational information, and the American Lung Association, which also provides clinical trial information and resources. Some teaching hospitals and major medical centers maintain their own research websites where they list asthma trials they're conducting.
When you find a trial you're interested in, here's what you'll typically encounter: First, there's an initial screening, which might be a phone conversation, online questionnaire, or brief in-person visit where research staff confirm you meet the basic study requirements. This screening is free and doesn't obligate you to participate further.
If you move forward, you'll attend a baseline visit. Researchers conduct lung function tests (spirometry, where you blow into a machine to measure how much air your lungs can hold and how quickly you can exhale), review your detailed asthma history, ask about your current symptoms and medication use, and may perform blood tests or allergy testing depending on the trial. You'll receive a thorough explanation of what the trial involves, the time commitment required, and any potential risks.
The actual study phase varies by trial. Some involve monthly visits; others require visits every few weeks. Many trials ask you to keep
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.